- Highlighted Item:
- Publication Date:Jan 2020
- Publication Type:Presentation
- Scientific Area:
- Industry Type:
Management of N-Nitrosamines - Use of Mirabilis based purge calculations to understand MI related risk and control strategy options
This presentation was given by Dr Andrew Teasdale, Senior Principal Scientist at AstraZeneca, as part of the 'Risk Assessment and Regulatory Decision Making for Alkyl Nitrosamines' webinar, on Tuesday 21st January 2020.